Gilead Sciences | 83.7300 / +0.13% |
Date/Time | 01/27 / 22:00 |
Chg. / Chg.(%) | 0.1100 / +0.13% |
Bid | 83.7000 / 2500 |
Ask | 83.7200 / 100 |
Open | 83.3300 |
Previous Close | 83.6200 |
High | 83.9700 |
Low | 83.1100 |
Volume [USD] | 260,171,895.5065 |
Volume [Units] | 4,042,044 |
Price fixings | 17368 |
ISIN | US3755581036 |
Security | GILD |
Exchange | NASDAQ |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 83.7300 | ![]() |
4,042,044 |
Cboe US | 83.72 | ![]() |
213,927 |
IEX | 83.70 | ![]() |
146,314 |
Xetra | 76.98 | ![]() |
4,803 |
TradeGate | 77.070 | ![]() |
4,769 |
Stuttgart | 76.990 | ![]() |
950 |
Euronext Mil.. | 76.90 | ![]() |
490 |
Frankfurt | 76.5400 | ![]() |
253 |
Vienna Globa.. | 77.00 | ![]() |
232 |
gettex | 77.130 | ![]() |
226 |
Berlin | 76.36 | ![]() |
0 |
Hannover | 76.38 | ![]() |
0 |
München | 76.68 | ![]() |
0 |
Düsseldorf | 76.81 | ![]() |
0 |
Hamburg | 76.38 | ![]() |
0 |
Lang & Schwa.. | 76.930 | ![]() |
|
Quotrix | 76.5200 | ![]() |
|
Euronext Mil.. | 80.78 | ![]() |
5 |
News
- Gilead's revenue down 5% to $7B in Q3
10/27/2022 / 22:03 - TeleTrader - US opens higher ahead of August inflation report
09/12/2022 / 15:31 - TeleTrader - Gilead Q2 revenue tops estimates at $6.26 billion
08/02/2022 / 22:04 - TeleTrader - Gilead's revenues up 3% to $6.6B in Q1
04/28/2022 / 22:04 - TeleTrader - Jyseleca® approved in Japan for ulcerative colitis
03/28/2022 / 08:01 - GlobeNewswire